Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation ESC 2025

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Presenter: Milind Y Desai

August 30, 2025

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

Presentation ACC 2022

Updated Cumulative Results Of Treatment With Mavacamten From The EXPLORER-LTE Cohort Of The MAVA-LTE Study In Patients With Obstructive Hypertrophic Cardiomyopathy

Presenter: Florian Rader

April 04, 2022

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

Presentation ECHO 2018

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

Presenter: Gerard P. Aurigemma

April 19, 2018

Presentation ECHO 2018

Hypertrophic Cardiomyopathy

Presenter: Muhamed Sarić

April 19, 2018

Presentation ECHO 2017

Hemodynamic Stress Testing

Presenter: Linda D. Gillam

April 02, 2017

Presentation ECHO 2017

Cases: Unusual Finding in HCM

Presenter: Linda D. Gillam

April 02, 2017

Presentation ECHO 2017

Echocardiolgraphy in Hypertrophic Cardiomyopathy

Presenter: Linda D. Gillam

April 01, 2017

Advertisement

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Updated Cumulative Results Of Treatment With Mavacamten From The EXPLORER-LTE Cohort Of The MAVA-LTE Study In Patients With Obstructive Hypertrophic Cardiomyopathy

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

Hypertrophic Cardiomyopathy

Hemodynamic Stress Testing

Cases: Unusual Finding in HCM

Echocardiolgraphy in Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content